Alpesh Saiduldina, PA | |
1775 N Sector Ct, Winchester, VA 22601-2859 | |
(540) 678-4312 | |
Not Available |
Full Name | Alpesh Saiduldina |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 1775 N Sector Ct, Winchester, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326586678 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Alpesh Saiduldina, PA 6647 Dunwich Way, Alexandria, VA 22315-2655 Ph: (703) 220-5646 | Alpesh Saiduldina, PA 1775 N Sector Ct, Winchester, VA 22601-2859 Ph: (540) 678-4312 |
News Archive
Thyroid cancer patients whose disease is at low risk of returning can be treated safely with a smaller amount of radiation following surgery, according to results from the world's longest running trial to investigate this.
A federal judge in Texas seemed sympathetic to the argument by GOP state officials that the Affordable Care Act soon will no longer be constitutional since Congress eliminated the penalty for not having insurance. The case was filed by 18 state attorneys general and two governors.
Lonza Bioscience is inviting visitors to explore its new dedicated website: bioscience.lonza.com. Filled with detailed application and product information, the website has been designed to support the work of scientists across the bioresearch, drug discovery and pharmaceutical manufacturing fields.
A recently released publication in the journal Psychology of Addictive Behaviors, "Prevention of Alcohol Use in Older Teens: A Randomized Trial of an Online Family Prevention Program" reveals successful results for an on-line, family-based prevention program, Smart Choices 4 Teens, which is designed to reduce alcohol use among 16 and 17-year old teens.
Eli Lilly and Company today commented on a ruling issued by the U.S. District Court for the Southern District of California granting a request by Amylin Pharmaceuticals for a temporary restraining order (TRO) related to litigation involving the two companies' diabetes collaboration agreement.
› Verified 7 days ago